SG Americas Securities’s Antares Pharma, Inc. ATRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-54,887
| Closed | -$225K | – | 3696 |
|
|
2022
Q1 | $225K | Sell |
54,887
-42,638
| -44% | -$155K | ﹤0.01% | 2364 |
|
|
2021
Q4 | $348K | Sell |
97,525
-39,793
| -29% | -$139K | ﹤0.01% | 2367 |
|
|
2021
Q3 | $500K | Buy |
137,318
+60,988
| +80% | +$247K | ﹤0.01% | 2507 |
|
|
2021
Q2 | $333K | Buy |
76,330
+48,010
| +170% | +$196K | ﹤0.01% | 2119 |
|
|
2021
Q1 | $116K | Buy |
28,320
+15,121
| +115% | +$65.5K | ﹤0.01% | 3011 |
|
|
2020
Q4 | $53K | Sell |
13,199
-92,872
| -88% | -$300K | ﹤0.01% | 3138 |
|
|
2020
Q3 | $286K | Sell |
106,071
-188,798
| -64% | -$522K | ﹤0.01% | 1959 |
|
|
2020
Q2 | $811K | Buy |
294,869
+154,049
| +109% | +$430K | 0.01% | 1623 |
|
|
2020
Q1 | $332K | Buy |
140,820
+121,481
| +628% | +$413K | ﹤0.01% | 2154 |
|
|
2019
Q4 | $91K | Sell |
19,339
-2,816
| -13% | -$11.5K | ﹤0.01% | 2980 |
|
|
2019
Q3 | $74K | Sell |
22,155
-17,843
| -45% | -$58.8K | ﹤0.01% | 2768 |
|
|
2019
Q2 | $132K | Buy |
39,998
+16,545
| +71% | +$47.9K | ﹤0.01% | 2665 |
|
|
2019
Q1 | $71K | Sell |
23,453
-24,733
| -51% | -$80.2K | ﹤0.01% | 3128 |
|
|
2018
Q4 | $131K | Buy |
+48,186
| New | +$159K | ﹤0.01% | 2577 |
|
|
2018
Q2 | – | Sell |
-12,052
| Closed | -$27K | – | 3623 |
|
|
2018
Q1 | $27K | Sell |
12,052
-28,398
| -70% | -$63.9K | ﹤0.01% | 3138 |
|
|
2017
Q4 | $80K | Buy |
40,450
+28,247
| +231% | +$61.5K | ﹤0.01% | 2905 |
|
|
2017
Q3 | $40K | Buy |
+12,203
| New | +$37.7K | ﹤0.01% | 3349 |
|
|
2017
Q2 | – | Sell |
-14,096
| Closed | -$40K | – | 3631 |
|
|
2017
Q1 | $40K | Buy |
+14,096
| New | +$33.9K | ﹤0.01% | 3137 |
|
|
2016
Q2 | – | Sell |
-103,113
| Closed | -$90K | – | 3107 |
|
|
2016
Q1 | $90K | Buy |
+103,113
| New | +$99.8K | ﹤0.01% | 2656 |
|
|
2014
Q4 | – | Sell |
-56,231
| Closed | -$103K | – | 3438 |
|
|
2014
Q3 | $103K | Buy |
+56,231
| New | +$123K | ﹤0.01% | 2365 |
|
|
2014
Q2 | – | Sell |
-15,884
| Closed | -$56K | – | 2764 |
|
|
2014
Q1 | $56K | Buy |
+15,884
| New | +$70.5K | ﹤0.01% | 2303 |
|
|
2013
Q4 | – | Sell |
-18,972
| Closed | -$77K | – | 3118 |
|
|
2013
Q3 | $77K | Buy |
+18,972
| New | +$82.9K | ﹤0.01% | 2718 |
|
Other funds holding ATRS
SG Americas Securities's ATRS Position: Q2 2022 in Review
SG Americas Securities sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 54,887 shares — an estimated $225K sold.
SG Americas Securities first reported a position in ATRS in Q3 2013 and held it in 22 quarters. The position peaked at $811K in Q2 2020. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.
- SG Americas Securities reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
- SG Americas Securities sold 54,887 Antares Pharma, Inc. shares in Q2 2022, an estimated $225K.
- SG Americas Securities first reported a position in Antares Pharma, Inc. in Q3 2013 and held it in 22 quarters.
- SG Americas Securities's Antares Pharma, Inc. position peaked at $811K in Q2 2020.
- 1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.
Based on SG Americas Securities's 13F filing for Q2 2022, filed 29 Jul 2022.